{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-283140","form_type":"8-K","ticker":"KLRS","cik":"0001754068","company_name":"Kalaris Therapeutics, Inc.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.474048+00:00","generated_at":"2026-05-29T00:21:27.384655+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CEO Diana Brainard departs; President/CFO Vikas Sinha named CEO effective Dec 19, 2024","bullets":["Diana Brainard resigned as CEO and director effective Dec 19; no disagreement with company on operations, policies, or practices.","Vikas Sinha (President, CFO since 2019) appointed CEO and principal executive officer same day; he has over 20 years life sciences finance experience.","Brainard receives $1.88M lump sum (36-mo salary), $376k target bonus, $100k merger completion bonus, and acceleration of 371,525 RSUs.","Company previously disclosed proposed merger with Kalaris Therapeutics, Inc.; Sinha served as CFO of Alexion Pharma (ALXN) previously."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-283140","json":"https://secwatch.observer/filing/0001193125-24-283140.json","markdown":"https://secwatch.observer/filing/0001193125-24-283140.md","text":"https://secwatch.observer/filing/0001193125-24-283140.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1754068/000119312524283140/0001193125-24-283140-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1754068/000119312524283140/d905140d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:21:27.384655+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}